12, 2024 /PRNewswire/ -- The vascular stents market is anticipated to grow ... Key players include Medtronic, Abbott, Boston Scientific, and several others across various regions, indicating ...

Key players include Medtronic, Abbott ... Abbott's range of vascular stents includes carotid, Supera Peripheral, Xience drug-eluting, and peripheral vascular stents. The company's focus on ...

Sri Jayadeva Institute of Cardiovascular Sciences and Research, in collaboration with Medtronic and Govindaraju ... High-quality medicated imported stents will be given for free to all the patients.

Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 13% over the last month. We, however wanted to have a closer look at its key financial indicators as ...

Medtronic faced challenges, including poor focus, lack of innovation, and COVID-19 impact, leading to share price stagnation since 2018. Despite recent improvements in performance, Medtronic ...

Medtronic delivered a strong first-quarter earnings report. The company benefits from continued market adoption of several new product launches over the past year. The stock looks attractive ...

Carillon Eagle Growth & Income Fund highlighted stocks like Medtronic plc (NYSE:MDT), in the second quarter 2024 investor letter. Medtronic plc (NYSE:MDT) develops, manufactures, and distributes ...

This rate is the lowest recorded for any carotid stent or embolic protection device pivotal trial to date. The trial's findings were initially presented in May at the Leipzig Interventional Course ...

TEL AVIV - InspireMD, Inc. (NASDAQ:NSPR), a medical device company, has submitted a Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its CGuard Prime carotid ...